Page last updated: 2024-08-24

irinotecan and Hypoalbuminemia

irinotecan has been researched along with Hypoalbuminemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Baek, SE; Chung, HC; Han, Y; Hong, M; Jeung, HC; Jung, M; Kim, CG; Kim, H; Kim, HS; Kim, JH; Lee, CK; Lee, G; Lee, JH; Lee, SY; Rha, SY; Shin, SJ	1
Alliot, C; Barrios, M	1
Boige, V; Elias, D; Estphan, G; Laplanche, A; Malka, D; Pocard, M; Raynard, B	1

Trials

1 trial(s) available for irinotecan and Hypoalbuminemia

Article	Year
Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis. Journal of surgical oncology, 2005, Jun-15, Volume: 90, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fluorouracil; Glucose; Hemodilution; Humans; Hyperthermia, Induced; Hypoalbuminemia; Infusions, Parenteral; Irinotecan; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Postoperative Period; Prospective Studies; Red-Cell Aplasia, Pure; Treatment Outcome	2005

Article

Year

Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis.

Journal of surgical oncology, 2005, Jun-15, Volume: 90, Issue:4

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fluorouracil; Glucose; Hemodilution; Humans; Hyperthermia, Induced; Hypoalbuminemia; Infusions, Parenteral; Irinotecan; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Postoperative Period; Prospective Studies; Red-Cell Aplasia, Pure; Treatment Outcome

2005

Other Studies

2 other study(ies) available for irinotecan and Hypoalbuminemia

Article	Year
Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancer. European journal of cancer (Oxford, England : 1990), 2022, Volume: 172 Topics: Disease Progression; Humans; Hypoalbuminemia; Immune Checkpoint Inhibitors; Irinotecan; Programmed Cell Death 1 Receptor; Stomach Neoplasms	2022
Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly. British journal of cancer, 2004, May-17, Volume: 90, Issue:10 Topics: Age Factors; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Clinical Trials as Topic; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Costs; Humans; Hypoalbuminemia; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Prognosis; Sample Size	2004

Article

Year

Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancer.

European journal of cancer (Oxford, England : 1990), 2022, Volume: 172

Topics: Disease Progression; Humans; Hypoalbuminemia; Immune Checkpoint Inhibitors; Irinotecan; Programmed Cell Death 1 Receptor; Stomach Neoplasms

2022

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly.

British journal of cancer, 2004, May-17, Volume: 90, Issue:10

Topics: Age Factors; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Clinical Trials as Topic; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Costs; Humans; Hypoalbuminemia; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Prognosis; Sample Size

2004